Which countries run stem-cell trials for Osteoporosis & Bone Health?
Sampled registrations place sites in 10 countries. United States is the largest single contributor at roughly 36% of country mentions. Snapshot 2026-08-29.
Country distribution
| Country | Studies with a site there |
|---|---|
| United States | 5 |
| Antigua and Barbuda | 1 |
| Switzerland | 1 |
| Spain | 1 |
| China | 1 |
| United Kingdom | 1 |
| Belgium | 1 |
| Denmark | 1 |
| Indonesia | 1 |
| France | 1 |
A study with sites in several countries is counted once per country, taken from the location block of each registry record.
What the map means for Osteoporosis & Bone Health
Registered activity is limited and academic. Commercially, bone-density claims are usually bundled into 'anti-ageing' packages rather than sold as a standalone osteoporosis treatment, which makes them harder to compare with drug evidence.
Where recruitment is actually open
| Country | Open studies with a site there |
|---|---|
| United Kingdom | 1 |
| Belgium | 1 |
What travelling for a trial actually involves
Distance changes the risk calculus. Registered studies are designed around continuity of care, so a site will normally decline participants it cannot monitor — which is exactly the safeguard a commercial clinic does not apply.
Multi-country studies, named
Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.
No sampled study for this condition lists sites in more than one country, so the research base here is made of single-centre work rather than multinational collaboration.
Why trial geography is not a shortlist
Where studies happen reflects who funds and who authorises them. Treating that as a ranking of care quality confuses the research system with the treatment market, two things that overlap far less than medical-tourism marketing implies.
Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.
When these studies started
Registrations by start year since 2020: 2020 (1), 2022 (2), 2023 (1), 2025 (1). Activity for this condition spans 2005 to 2025, which shows whether interest is growing, flat or past its peak.
Frequently asked
Which countries run stem-cell trials for Osteoporosis & Bone Health?
Sites are registered in 10 countries; the largest is United States (~36% of country mentions, 2026-08-29).
Does a country with many trials mean better treatment there?
No. Registration volume reflects the research and regulatory environment, not the quality of care a private clinic there will provide.
Are trial sites and commercial clinics the same thing?
Mostly no. Some clinics imply an association with local research institutions; the registry record names the actual sponsor and site, which settles it.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.